Longitudinal Follow-Up of Serum and Urine Biomarkers Indicative of COVID-19-Associated Acute Kidney Injury: Diagnostic and Prognostic Impacts

被引:2
|
作者
Lablad, Yahya [1 ]
Vanhomwegen, Charlotte [1 ]
De Prez, Eric [1 ]
Antoine, Marie-Helene [1 ]
Hasan, Sania [1 ]
Baudoux, Thomas [1 ,2 ]
Nortier, Joelle [1 ]
机构
[1] Univ Libre Bruxelles, Fac Med, Lab Expt Nephrol, Erasme Campus,808 Route Lennik, B-1070 Brussels, Belgium
[2] Erasme Univ Hosp, Dept Nephrol Dialysis & Renal Transplantat, Erasme Campus, B-1070 Brussels, Belgium
关键词
AKI; COVID-19; biomarkers; NGAL; LAP; CCL14; cystatin C; suPAR; SOLUBLE UROKINASE RECEPTOR; COVID-19; PATIENTS;
D O I
10.3390/ijms242216495
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In patients hospitalized for severe COVID-19, the incidence of acute kidney injury (AKI) is approximately 40%. To predict and understand the implications of this complication, various blood and urine biomarkers have been proposed, including neutrophil gelatinase-associated lipocalin (NGAL), chemokine (C-C motif) ligand 14 (CCL14), cystatin C, leucine aminopeptidase (LAP), and soluble urokinase plasminogen activator (suPAR). This study, conducted between mid-January and early May 2021, aimed to assess the diagnostic and prognostic capabilities of these biomarkers in a cohort of COVID-19 patients monitored during the initial two weeks of hospitalization. Among the 116 patients included in this study, 48 developed AKI within the first three days of hospitalization (41%), with 29 requiring intensive care unit (ICU) admission, and the overall mortality rate was 18%. AKI patients exhibited a statistically significant increase in urinary LAP levels, indicating acute tubular injury as a potential mechanism underlying COVID-19-related renal damage. Conversely, urinary NGAL and CCL-14 excretion rates did not differ significantly between the AKI and non-AKI groups. Importantly, elevated plasma suPAR and cystatin C levels upon admission persisted throughout the first week of hospitalization and were associated with unfavorable outcomes, such as prolonged ICU stays and increased mortality, irrespective of AKI development. In conclusion, this study underscores the early predictive value of urinary LAP levels in identifying acute tubular injury in COVID-19-induced AKI. Moreover, elevated plasma suPAR and cystatin C levels serve as valuable prognostic markers, offering insights into the short-term morbidity and mortality risks among COVID-19 patients, regardless of AKI occurrence. These findings shed light on the complex interplay between COVID-19, renal injury, and biomarkers with diagnostic and prognostic potential.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Inappropriate Heart Rate Response to Hypotension in Critically Ill COVID-19-Associated Acute Kidney Injury
    Verney, Charles
    Legouis, David
    Voiriot, Guillaume
    Fartoukh, Muriel
    Labbe, Vincent
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06)
  • [22] Evaluation of serum and urine neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury in horses
    Siwinska, Natalia
    Zak, Agnieszka
    Paslawska, Urszula
    JOURNAL OF VETERINARY RESEARCH, 2021, 65 (02) : 245 - 252
  • [23] Outcomes of COVID-19-associated mucormycosis epidemic in India: A prospective 2-year follow-up study
    Yadav Vishav
    Bhagat Sanjeev
    Goel Khushboo
    Sibia Raminderpal S
    Sharma Dinesh K
    Sidhu Talvir
    Rajdev Saivi
    Aggarwal Ankita
    世界耳鼻咽喉头颈外科杂志(英文), 2025, 11 (01)
  • [24] Outcomes of COVID-19-associated mucormycosis epidemic in India: A prospective 2-year follow-up study
    Yadav, Vishav
    Bhagat, Sanjeev
    Goel, Khushboo
    Sibia, Raminderpal S.
    Sharma, Dinesh K.
    Sidhu, Talvir
    Rajdev, Saivi
    Aggarwal, Ankita
    WORLD JOURNAL OF OTORHINOLARYNGOLOGY-HEAD & NECK SURGERY, 2025, 11 (01): : 66 - 73
  • [25] Foe and friend in the COVID-19-associated acute kidney injury: an insight on intrarenal renin-angiotensin system
    Xu, Chuanming
    Chen, Yanting
    Yu, Jun
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2022, 54 (01) : 1 - 11
  • [26] Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis
    Kravchenko, Dmitrij
    Isaak, Alexander
    Mesropyan, Narine
    Bischoff, Leon M.
    Pieper, Claus C.
    Attenberger, Ulrike
    Kuetting, Daniel
    Zimmer, Sebastian
    Hart, Christopher
    Luetkens, Julian A.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [27] Renal replacement therapy for critically ill patients with COVID-19-associated acute kidney injury: A review of current knowledge
    Shemies, Rasha Samir
    Nagy, Eman
    Younis, Dalia
    Sheashaa, Hussein
    THERAPEUTIC APHERESIS AND DIALYSIS, 2022, 26 (01) : 15 - 23
  • [28] Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up
    Kanberg, Nelly
    Simren, Joel
    Eden, Arvid
    Andersson, Lars-Magnus
    Nilsson, Staffan
    Ashton, Nicholas J.
    Sundvall, Par-Daniel
    Nellgard, Bengt
    Blennow, Kaj
    Zetterberg, Henrik
    Gisslen, Magnus
    EBIOMEDICINE, 2021, 70
  • [29] Myocardial Injury as a Prognostic Factor in Mid- and Long-Term Follow-Up of COVID-19 Survivors
    Izquierdo, Andrea
    Mojon, Diana
    Bardaji, Alfredo
    Carrasquer, Anna
    Calvo-Fernandez, Alicia
    Carreras-Mora, Jose
    Giralt, Teresa
    Perez-Fernandez, Silvia
    Farre, Nuria
    Soler, Cristina
    Sola-Richarte, Claudia
    Cabero, Paula
    Vaquerizo, Beatriz
    Marrugat, Jaume
    Ribas, Nuria
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (24)
  • [30] Clinical and Biochemical Characteristics of COVID-19-Associated Acute Kidney Injury (COVAKI): A Proof-of-Concept Case-Control Study
    Kumthekar, Girish V.
    Nagarkar, Manasi S.
    Purandare, Veena
    Shukla, Sharvari
    Yeravdekar, Rajiv
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)